Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine
1. ANVISA approves Valneva’s Ixchiq vaccine for chikungunya in Brazil. 2. This is the first licensed chikungunya vaccine for endemic countries. 3. Valneva plans extensive trials to support Ixchiq's FDA approval in the U.S. 4. High chikungunya cases in Brazil highlight the vaccine's market potential. 5. Valneva stock price rose 10.02% following the vaccine approval news.